Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

NCT01879774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2022-05-25

No results posted yet for this study

Summary

The aim of this epidemiological study is to characterize the neuropsychological and motoric performance in patients with hyponatremia. Newer studies revealed an association between mild hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the paradigm of an "asymptomatic" hyponatremia. Until now, there is no known detailed investigation and characterisation of the cognitive and motoric performance or limitation by this disorder. Therefore this study will investigate patients with hyponatremia on the basis of neuropsychological and neurological tests.

Conditions

Interventions

OTHER

Neuropsychological and motoric tests

1. Neuropsychological tests * Mini Mental Status Test * Dem-Tect * Rey-Osterrieth Complex Figure Test * Trailmaking Test * Beck Depression Inventory * d2-R (optional) 2. Motoric tests * modified UPDRS (Unified Parkinson Disease Rating Scale) Part III * Timed-up-and-go Test * Halstead Fingertapping Test * AIMS (Abnormal involuntary movement scale) 3. EEG (only in patients with hyponatremia) 4. MRI (only in patients with hyponatremia)

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Volker Burst, MD · University Hospital of Cologne

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2022-01-31
Completion
2022-04-30

Countries

  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01879774 on ClinicalTrials.gov